Literature DB >> 23585991

Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report.

Yakup Albayrak1, Görkem Karakas Uğurlu, Mustafa Uğurlu, Ali Cayköylü.   

Abstract

Entities:  

Year:  2012        PMID： 23585991      PMCID： PMC3622530          DOI： 10.4088/PCC.12l01369

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  7 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.

Authors:  Ali Cayköylü; Yakup Albayrak; Görkem Karakaş Uğurlu; Okan Ekinci
Journal:  Acta Neurol Belg       Date:  2011-03       Impact factor: 2.396

3.  Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.

Authors:  Yakup Albayrak; Okan Ekinci
Journal:  J Clin Psychopharmacol       Date:  2012-10       Impact factor: 3.153

4.  Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.

Authors:  Tsutomu Furuse; Kenji Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2010-03-06       Impact factor: 3.455

5.  Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.

Authors:  Tsutomu Furuse; Kenji Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2010-04-24       Impact factor: 3.455

6.  High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

Authors:  Masatomo Ishikawa; Kiichi Ishiwata; Kenji Ishii; Yuichi Kimura; Muneyuki Sakata; Mika Naganawa; Keiichi Oda; Ryousuke Miyatake; Mihisa Fujisaki; Eiji Shimizu; Yukihiko Shirayama; Masaomi Iyo; Kenji Hashimoto
Journal:  Biol Psychiatry       Date:  2007-07-30       Impact factor: 13.382

7.  Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Authors: 
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910
  7 in total
  2 in total

1.  A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.

Authors:  Yakup Albayrak; Murat Beyazyüz; Özlem Abbak; Ece Altındağ
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-02-28       Impact factor: 2.582

2.  Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three cases.

Authors:  Yakup Albayrak; Kenji Hashimoto
Journal:  Psychiatry Investig       Date:  2013-10-24       Impact factor: 2.505
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.